These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19995776)

  • 1. Deep vein thrombosis prophylaxis.
    Weber KL; Zuckerman JD; Watters WC; Turkelson CM
    Chest; 2009 Dec; 136(6):1699-1700. PubMed ID: 19995776
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks vs benefits in total joint surgery.
    Lotke PA
    Chest; 1999 Sep; 116(3):843-5. PubMed ID: 10492303
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
    Olsen J; Gundgaard J; Borris LC
    Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
    [No Abstract]   [Full Text] [Related]  

  • 4. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
    Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
    JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome.
    Muntz JE; O'Connor PJ; Yin H; Vogenberg FR
    Am J Orthop (Belle Mead NJ); 2007 Apr; 36(4):193-7. PubMed ID: 17515185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
    Colwell CW
    Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis and peripheral nerve blocks in patients undergoing joint arthroplasty.
    Chelly JE; Schilling D
    J Arthroplasty; 2008 Apr; 23(3):350-4. PubMed ID: 18358371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
    Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
    Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep vein thrombosis and pulmonary embolism in patients undergoing total hip arthroplasty: the promise of new oral anticoagulants.
    Muntz J
    J Surg Orthop Adv; 2011; 20(4):215-9. PubMed ID: 22381412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
    Friedman RJ
    Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
    Kaatz S; Spyropoulos AC
    Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.
    Friedman RJ
    J Am Acad Orthop Surg; 2007 Mar; 15(3):148-55. PubMed ID: 17341671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study.
    Sudo A; Sano T; Horikawa K; Yamakawa T; Shi D; Uchida A
    J Orthop Surg (Hong Kong); 2003 Dec; 11(2):174-7. PubMed ID: 14676343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous thromboembolic disease after total hip and knee arthroplasty.
    Haas SB; Barrack RL; Westrich G; Lachiewicz PF
    J Bone Joint Surg Am; 2008 Dec; 90(12):2764-80. PubMed ID: 19047723
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
    Lotke PA; Callaghan JJ; Dorr LD; Engh GH; Hanssen AD; Healy WL; Lachiewicz PF; Lonner JH; Nelson C; Ranawat CS; Ritter MA; Salvati EA; Sculco TP; Thornhill TS
    J Bone Joint Surg Am; 2006 May; 88(5):1163; author reply 1163-5. PubMed ID: 16651602
    [No Abstract]   [Full Text] [Related]  

  • 17. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
    Lachiewicz PF
    Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
    Zufferey PJ; Samama CM; Rosencher N
    Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.